Table 1.

Pre-treatment characteristics of the investigated patients

	Stage 1 (n=14)	Stage 2 (n=71)
Demography
Sex, F (n)*	7	32
Age, years [mean ± SD]†	37.1 [± 19.3]	36.9 [± 15.8]
Geographical origin
Malawi, n	3	27
Uganda, n	11	44
CSF examinations
Trypanosome positive, n	0	64
WBC/μL (median, range)	3 [2–5]	21 [4–1140]

* Fisher’s exact test, no significant differences.

† Mann–Whitney U test, no significant differences.